Novuson has been recognized by MedTech Outlook Magazine as the exclusive recipient of “Top 10 Medical Device Startups - 2022,” based on our proprietary methodology, reflecting its position in the industry. This profile has been developed by the MedTech Outlook research and editorial team based on insights from an interview with Stuart B. Mitchell, PhD, CEO, Founder, and Chief Science Officer.

Novuson

Company
Novuson

Management
Stuart B. Mitchell, PhD, CEO, Founder, and Chief Science Officer

Description
Novuson is developing its direct therapeutic ultrasound technology platform for coagulation and hemostatic control in surgical and trauma procedures.